Finance

Beta
Lists
CNBX:OTCMKTS
CNBX Pharmaceuticals Inc
$0.00020
0.00%
(0.00) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CNBX...
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
444.80
Avg. vol.
28.27M
Volume
20.01K
52-wk high
$0.01
52-wk low
$0.00
EPS
-$0.00
Beta
-0.21
Shares outstanding
1.23B
No. of employees
1
Open
$0.00
High
$0.00
Low
$0.00
Mkt. cap
444.80
Avg. vol.
28.27M
Volume
20.01K
52-wk high
$0.01
52-wk low
$0.00
EPS
-$0.00
Beta
-0.21
Shares outstanding
1.23B
No. of employees
1
News stories
From sources across the web
About CNBX Pharmaceuticals Inc
CEO-
Employees1
Founded2004
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
40.38K
129.73K
64.00K
72.96K
Operating expense
40.38K
129.73K
64.00K
72.96K
Total operating expenses
40.38K
129.73K
64.00K
72.96K
Operating income
-40.38K
-129.73K
-64.00K
-72.96K
Other non operating income
-
-
-
-
EBT including unusual items
-59.73K
-150.11K
-113.72K
-44.10K
EBT excluding unusual items
-59.73K
-150.11K
-113.72K
-44.10K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-59.73K
-150.11K
-113.72K
-44.10K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
28.86K
Interest expense
-19.35K
-18.28K
-49.72K
-
Net interest expenses
-19.35K
-18.28K
-49.72K
28.86K
Depreciation and amortization charges
-
-
-
-
EBITDA
-22.30K
-111.65K
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more